Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9UH77: Variant p.Ser433Gly

Kelch-like protein 3
Gene: KLHL3
Feedback?
Variant information Variant position: help 433 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Serine (S) to Glycine (G) at position 433 (S433G, p.Ser433Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and polar (S) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In PHA2D; decreased interaction with WNK4. Any additional useful information about the variant.


Sequence information Variant position: help 433 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 587 The length of the canonical sequence.
Location on the sequence: help AYSYKTNEWFFVAPMNTRRS S VGVGVVEGKLYAVGGYDGAS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         AYSYKTNEWFFVAPMNTRRSSVGVGVVEGKLYAVGGYDGAS

Mouse                         AYSYKTNEWFFVAPMNTRRSSVGVGVVEGKLYAVGGYDGAS

Rat                           AYSYKTNEWFFVAPMNTRRSSVGVGVVEGKLYAVGGYDGAS

Bovine                        AYSYKTNEWFFVAPMNTRRSSVGVGVVEGKLYAVGGYDGAS

Zebrafish                     AYNPKANEWMFVAPMNTRRSSVGVGVVDGKLYAVGGYDGAS
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 587 Kelch-like protein 3
Repeat 396 – 441 Kelch 3
Modified residue 433 – 433 Phosphoserine; by PKA and PKC
Mutagenesis 433 – 433 S -> AN. Abolished phosphorylation by PKC, promoting ubiquitination and degradation of WNK4.
Mutagenesis 433 – 433 S -> ED. Mimics phosphorylation, preventing binding and degradation of WNK4.



Literature citations
Impaired degradation of WNK by Akt and PKA phosphorylation of KLHL3.
Yoshizaki Y.; Mori Y.; Tsuzaki Y.; Mori T.; Nomura N.; Wakabayashi M.; Takahashi D.; Zeniya M.; Kikuchi E.; Araki Y.; Ando F.; Isobe K.; Nishida H.; Ohta A.; Susa K.; Inoue Y.; Chiga M.; Rai T.; Sasaki S.; Uchida S.; Sohara E.;
Biochem. Biophys. Res. Commun. 467:229-234(2015)
Cited for: PHOSPHORYLATION AT SER-10; THR-295; THR-375; SER-376 AND SER-433; CHARACTERIZATION OF VARIANT PHA2D GLY-433; MUTAGENESIS OF SER-433; KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron.
Louis-Dit-Picard H.; Barc J.; Trujillano D.; Miserey-Lenkei S.; Bouatia-Naji N.; Pylypenko O.; Beaurain G.; Bonnefond A.; Sand O.; Simian C.; Vidal-Petiot E.; Soukaseum C.; Mandet C.; Broux F.; Chabre O.; Delahousse M.; Esnault V.; Fiquet B.; Houillier P.; Bagnis C.I.; Koenig J.; Konrad M.; Landais P.; Mourani C.; Niaudet P.; Probst V.; Thauvin C.; Unwin R.J.; Soroka S.D.; Ehret G.; Ossowski S.; Caulfield M.; Bruneval P.; Estivill X.; Froguel P.; Hadchouel J.; Schott J.J.; Jeunemaitre X.;
Nat. Genet. 44:456-460(2012)
Cited for: VARIANTS PHA2D GLY-228; MET-361; TRP-362; TRP-384; VAL-398; LEU-410; LEU-426; ASN-432; GLY-433; VAL-500; HIS-528; CYS-528 AND LYS-529; FUNCTION; SUBCELLULAR LOCATION; TISSUE SPECIFICITY;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.